Skip to main content
Figure 1 | Journal of Medical Case Reports

Figure 1

From: Efficacy and safety of tenofovir in a kidney transplant patient with chronic hepatitis B and nucleos(t)ide multidrug resistance: a case report

Figure 1

Alanine aminotransferase and creatinine clearance levels during nucleos(t)ide analog therapy. Because various physicians in various hospitals have separately participated in nucleos(t)ide analog therapy in different phases, parameters of liver enzymes, renal function and DNA load from month 1 to month 60 have not been recorded. Fluctuating alanine amino transferase levels showed during nucleos(t)ide analog therapy. Two bottom of creatinine clearance were present in month 104 and in month 133. The box showed the nucleos(t)ide analog-resistant mutations by sequence analysis. LVD, lamivudine; ETV, entecavir; ADV, adefovir; LdT, telbivudine; TDF, tenofovir; wt,wild-type.

Back to article page

Journal of Medical Case Reports

ISSN: 1752-1947